Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Donaldson Company Reports Record Fiscal SecondQuarter 2022 Results and Raises Guidance

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Donaldson Company has just announced their exceptional fiscal second-quarter 2022 results, setting a new record with a net profit of $71.8 million, marking a significant 27.7% increase compared to the previous year.

The company also paid out dividends totaling $27.2 million and engaged in share repurchases during this period. Sales for the quarter saw a substantial 18.2% growth, reaching $802.5 million, which had a positive impact on their earnings per share (EPS).

With such strong performance, Donaldson has decided to raise its fiscal 2022 sales and EPS guidance, attributing this decision to a better-than-expected sales outlook. As a result, the company’s stock price experienced a surge of over 4% in premarket trading following the release of the earnings report.

Analysts are now setting their sights on Donaldson stock, with a median target price of $65.62 and a high estimate of $73.00, as well as a low estimate of $51.00. Donaldson is known for its expertise in the manufacture of filtration systems and replacement parts, operating through various segments such as Engine Products and Industrial Products.

As of February 28, 2024, Donaldson Company‘s future looks bright as they continue to thrive in their industry.

Donaldson Company, Inc. (DCI) Stock Soars on Strong Performance – February 28, 2024

On February 28, 2024, Donaldson Company, Inc. (DCI) showed strong performance in the stock market, trading near the top of its 52-week range and above its 200-day simple moving average. DCI closed at $67.14, with a price increase of $0.48 since the market last closed, representing a 0.72% rise.

Investors in DCI were pleased to see the stock performing well, especially with the additional after-hours trading increase of $0.11. DCI is a global leader in filtration solutions and has a strong track record of delivering consistent performance and value to its shareholders. The company’s focus on innovation, quality, and sustainability has helped it maintain a competitive edge in the market and attract investors looking for long-term growth opportunities.

Overall, the stock performance of DCI on February 28, 2024, was impressive, with the company demonstrating strength and resilience in the face of market volatility. Investors will be keeping a close eye on DCI in the coming days to see if the positive momentum continues.

DCI Stock Performance Analysis: Revenue and Net Income Increase, EPS at $2.90

DCI is a global leader in filtration solutions for various industries. On February 28, 2024, the company’s stock performance was closely watched. According to CNN Money, DCI reported a total revenue of $3.43 billion over the past year, with a quarterly revenue of $846.30 million. This represents a 3.76% increase in total revenue since the previous year, but a 3.77% decrease since the last quarter. In terms of net income, DCI reported a total of $358.80 million over the past year, with a quarterly net income of $92.10 million. Earnings per share (EPS) for DCI were reported at $2.90 over the past year, with a quarterly EPS of $0.75. Overall, DCI’s stock performance on February 28, 2024, showed mixed results with some positive indicators of growth in total revenue, net income, and earnings per share over the past year. Investors will be closely monitoring DCI’s future financial reports.

Tags: DCI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Fiscal (2)

AvidXchanges Strong Financial Outlook Projected EBITDA Exceeds Previous Estimates

DVY stock news

AvidXchanges Financial Forecast for Fiscal Year 2024

Biotechnology Stock Exchange

Ginkgo Bioworks Acquires Patch Biosciences Investing in AI Technology and Talent

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com